India's out-of-pocket health expenditure remains among the world's highest at roughly 47% of total health spending, according to the National Health Accounts published by the Ministry of Health. Despite Ayushman Bharat covering 55 crore beneficiaries on paper, structural gaps in public hospital capacity, drug pricing, and primary care access ensure that families continue to bear catastrophic costs — pushing an estimated 55 million Indians below the poverty line annually.
Here is a number that should stop every policy debate in its tracks: 55 million Indians pushed below the poverty line in a single year — not by flood, not by famine, but by a hospital bill. According to the World Health Organization's Global Health Expenditure Database, India's out-of-pocket health spending hovers near 47% of total health expenditure, a figure that places the world's largest generic-drug manufacturer in the company of nations with a fraction of its pharmaceutical firepower.
The contradiction is so stark it almost reads as satire. India vaccinates children across Africa and Southeast Asia. Indian pharmaceutical companies supply 20% of the world's generic medicines by volume, according to the Indian Brand Equity Foundation. Yet inside the country, a diabetic schoolteacher in Varanasi or a pregnant farmworker in Gadchiroli reaches into her own pocket for the same tablet her country exported at pennies per dose.
This is not a gap. It is a canyon — and it is engineered by design choices no single scheme has yet undone.
The Ayushman Illusion: Coverage on Paper, Absence on the Ground
Ayushman Bharat — Pradhan Mantri Jan Arogya Yojana, the world's largest government-funded health insurance programme — covers approximately 55 crore beneficiaries, according to the National Health Authority's own dashboard. On paper, that is transformative. In practice, the scheme reimburses hospitalisation costs at empanelled facilities. What it does not cover is the far more frequent encounter most Indians have with the health system: the outpatient visit.
National Sample Survey data consistently shows that outpatient care — the consultation, the diagnostic test, the strip of antibiotics — accounts for over 60% of household out-of-pocket health spending. Ayushman Bharat does not touch this. A labourer who visits a private clinic for a persistent cough, gets a chest X-ray, and walks out with a prescription has spent ₹800–₹1,500 of his own money on an encounter the flagship scheme was never built to intercept.
India Herald's read of what is really driving this is uncomfortable but clear: the architecture of protection was built around the catastrophic (hospitalisation) while ignoring the chronic (outpatient), and it is the chronic that bleeds families dry over years, not the single catastrophic event.
NITI Aayog's own Health Index reports have flagged that states like Bihar, Uttar Pradesh, and Madhya Pradesh — home to a combined population larger than most European nations — have the weakest density of functional primary health centres. When a government facility does not stock the drug, does not have the doctor on seat, or requires a 40-kilometre bus ride, the private clinic two lanes away wins by default. And the private clinic sets its own price.
The 2.1% Problem: Why India's Health Budget Cannot Keep Its Own Promises
The National Health Policy 2017, a document the government authored with considerable fanfare, committed India to raising public health expenditure to 2.5% of GDP by 2025. According to the latest Economic Survey and Union Budget documents, actual government health expenditure stands at roughly 2.1% of GDP as of the 2025-26 fiscal — a meaningful improvement from the 1.2% of a decade ago, but still short of the self-imposed target and well below the global average of approximately 6%, per WHO data.
That missing fraction of a percentage point is not an abstraction. It is the reason a district hospital in Jharkhand has two doctors for 300 beds. It is why the Comptroller and Auditor General's performance audits of state health missions routinely flag vacancies exceeding 30-40% in specialist positions at community health centres. Every unfilled post is a patient redirected to the private sector — and every redirection is an out-of-pocket charge the government's own underinvestment created.
Medicines: The Largest Single Drain on Family Wallets
Buried inside the National Health Accounts data is a detail that reframes the entire debate: medicines alone constitute the single largest component of out-of-pocket spending, accounting for 40–50% of total OOPE, depending on the survey year. This is extraordinary for a country that is the world's pharmacy.
The Jan Aushadhi scheme — which offers generic medicines at 50–90% discounts through dedicated centres — has expanded to over 12,000 outlets, according to the Bureau of Pharma PSUs of India. Yet penetration remains thin. A 2023 assessment by researchers published in the Indian Journal of Public Health noted that awareness of Jan Aushadhi centres remained below 30% among surveyed patients in several states. The medicines exist. The distribution — geographical, informational — does not.
What Comes Next: The Structural Fix India Keeps Deferring
The pattern is now legible to anyone watching closely. India has built impressive top-layer schemes — Ayushman Bharat for catastrophic coverage, Jan Aushadhi for drug affordability, Health and Wellness Centres for primary care — but the connective tissue between them remains weak. The patient falls through the gaps because the gaps are where most healthcare actually happens: the outpatient visit, the diagnostic test, the chronic medication refill.
Where this goes next, in India Herald's assessment, is toward a reckoning that will be forced by fiscal reality rather than chosen by political will. As India's non-communicable disease burden rises — diabetes, hypertension, and cardiovascular conditions now account for over 60% of deaths, according to the Indian Council of Medical Research — the outpatient spending that Ayushman Bharat ignores will swell, not shrink. States that have experimented with outpatient drug coverage — Tamil Nadu's free generics programme being the most studied, as documented in Lancet Global Health — offer a proof of concept. Whether Delhi adopts that lesson nationally, or waits for the next survey to confirm what every district hospital already knows, will determine whether the 55-million number climbs or finally bends.
The world's pharmacy healing everyone except its own people is not a riddle. It is a budget line, a design choice, and a political priority — all of which are fixable, if anyone with the authority decides to fix them.
This report is journalistic, not medical advice; consult a qualified professional.
Reported and written with AI assistance under India Herald's editorial standards; a human editor governs publication.
More from India Herald
Key Takeaways
- India's out-of-pocket health expenditure remains ~47% of total health spending — among the world's highest — pushing an estimated 55 million citizens below the poverty line annually, per WHO data.
- Ayushman Bharat covers hospitalisation but not outpatient care, which accounts for over 60% of household health spending according to National Sample Survey data — a structural blind spot, not a bug.
- Government health expenditure at ~2.1% of GDP still falls short of India's own 2.5% National Health Policy 2017 target, with specialist vacancies at community health centres routinely exceeding 30-40% per CAG audits.
- Medicines alone constitute 40-50% of out-of-pocket health costs despite India being the world's largest generic drug manufacturer — Jan Aushadhi awareness remains below 30% in several states.
- Tamil Nadu's free generics programme offers a tested model; whether Delhi scales it nationally will determine if India's health-poverty spiral bends or deepens as chronic diseases surge.
By the Numbers
- 55 million Indians pushed below the poverty line annually by health costs — WHO Global Health Expenditure Database
- India's OOPE at ~47% of total health expenditure vs global average of ~18% — National Health Accounts, Ministry of Health
- Outpatient care accounts for over 60% of household out-of-pocket health spending — National Sample Survey
- Medicines constitute 40-50% of total OOPE despite India supplying 20% of global generics by volume — NHA data and IBEF
- Government health expenditure at ~2.1% of GDP vs the NHP 2017 target of 2.5% — Economic Survey / Union Budget
- Jan Aushadhi awareness below 30% among patients in several states — Indian Journal of Public Health
click and follow Indiaherald WhatsApp channel